Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study

OBJECTIVE: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been recently reported with favorable oncological outcomes as treatment of advanced epithelial ovarian cancer (EOC). The aim of this study was to demonstrate the feasibility of CRS+HIPEC with cisplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Coccolini, Federico, Campanati, Luca, Catena, Fausto, Ceni, Valentina, Ceresoli, Marco, Jimenez Cruz, Jorge, Lotti, Marco, Magnone, Stefano, Napoli, Josephine, Rossetti, Diego, De Iaco, Pierandrea, Frigerio, Luigi, Pinna, Antonio, Runnebaum, Ingo, Ansaloni, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302286/
https://www.ncbi.nlm.nih.gov/pubmed/25376916
http://dx.doi.org/10.3802/jgo.2015.26.1.54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302286/
https://www.ncbi.nlm.nih.gov/pubmed/25376916
http://dx.doi.org/10.3802/jgo.2015.26.1.54

Ejemplares similares